Effect of immunity on gene delivery into anterior horn motor neurons by live attenuated herpes simplex virus vector (Q45736046)

15 December 2017

title

Effect of immunity on gene delivery into anterior horn motor neurons by live attenuated herpes simplex virus vector (English)

1 reference

15 December 2017

0 references

1 reference

Kamiyama H

1

1 reference

15 December 2017

Kurimoto M

2

1 reference

15 December 2017

Yamamura J

3

1 reference

15 December 2017

Uwano T

4

1 reference

15 December 2017

Hirashima Y

5

1 reference

15 December 2017

Kurokawa M

6

1 reference

15 December 2017

Endo S

7

1 reference

15 December 2017

Shiraki K

8

1 reference

15 December 2017

publication date

1 August 2001

1 reference

15 December 2017

1 reference

15 December 2017

volume

8

1 reference

15 December 2017

issue

15

1 reference

15 December 2017

page(s)

1180-1187

1 reference

15 December 2017

cites work

Gene therapy in the CNS.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301503

Pre-existing herpes simplex virus 1 (HSV-1) immunity decreases, but does not abolish, gene transfer to experimental brain tumors by a HSV-1 vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301503

An inquiry into the mechanisms of herpes simplex virus latency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301503

Beta-galactosidase as a marker in the peripheral and neural tissues of the herpes simplex virus-infected mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301503

Herpes simplex virus latent RNA (LAT) is not required for latent infection in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301503

Replication-defective herpes simplex virus vectors for gene transfer in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301503

Introduction of the glutamate receptor subunit 1 into motor neurons in vitro and in vivo using a recombinant herpes simplex virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301503

Recovery of herpes-simplex virus from human trigeminal ganglions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301503

Infections with herpes simplex viruses (1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301503

Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301503

Recombinant IL-12 prevents formation of blocking IgA antibodies to recombinant adenovirus and allows repeated gene therapy to mouse lung.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301503

Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301503

A model system for in vivo gene transfer into the central nervous system using an adenoviral vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301503

Immune responses to adenoviral vectors during gene transfer in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301503

Immune responses to adenovirus vectors in the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301503

Long-term gene expression in the anterior horn motor neurons after intramuscular inoculation of a live herpes simplex virus vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301503

Latent herpes simplex virus in spinal ganglia of mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301503

Herpes-simplex virus from trigeminal ganglion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301503

Isolation of Herpes simplex virus from human trigeminal ganglia, including ganglia from one patient with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301503

Isolation of Latent Herpes Simplex Virus from the Superior Cervical and Vagus Ganglions of Human Beings

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301503

Murine cytotoxic T lymphocytes specific for herpes simplex virus type 1 recognize the immediate early protein ICP4 but not ICP0.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301503

Demonstration of Exogenous Genital Reinfection with Herpes Simplex Virus Type 2 by Restriction Endonuclease Fingerprinting of Viral DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301503

Demonstration of either endogenous recurrence or exogenous reinfection by resiriction endonuclease cleavage analysis of herpes simplex virus from patients with recrudescent genital herpes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301503

The function of herpes simplex virus genes: a primer for genetic engineering of novel vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301503

The principles of gene therapy for the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301503

Gene transfer to neurons using herpes simplex virus-based vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301503

Adenoviral gene transfer of ciliary neurotrophic factor and brain-derived neurotrophic factor leads to long-term survival of axotomized motor neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301503

A live non-neurovirulent herpes simplex virus vector expresses beta-galactosidase in the nervous system of the Wistar and Sprague-Dawley strain rat for a prolonged period

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301503

Acyclovir treatment of skin lesions results in immune deviation in mice infected cutaneously with herpes simplex virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301503

Expression of recombinant genes in myocardium in vivo after direct injection of DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301503

Recent advances in molecular histochemical techniques: in situ hybridization and southwestern histochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301503

Brain Tumor Therapy Using Genetically Engineered Replication-Competent Virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301503

Specific Patterns of Defective HSV-1 Gene Transfer in the Adult Central Nervous System: Implications for Gene Targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301503

RNA complementary to a herpesvirus alpha gene mRNA is prominent in latently infected neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301503

7 January 2021

Targeting and gene expression in spinal cord motor neurons following intramuscular inoculation of an HSV-1 vector.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301503

7 January 2021

Utilization of the herpes simplex virus type 1 latency-associated regulatory region to drive stable reporter gene expression in the nervous system.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301503

7 January 2021

Immunological instability of persistent adenovirus vectors in the brain: peripheral exposure to vector leads to renewed inflammation, reduced gene expression, and demyelination

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301503

7 January 2021

Evidence that neurons harbor latent herpes simplex virus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301503

7 January 2021

The mouse model and understanding immunity to herpes simplex virus.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301503

7 January 2021

Potent neutralizing activity associated with anti-glycoprotein D specificity among monoclonal antibodies selected for binding to herpes simplex virions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301503

7 January 2021

Human CD8+ herpes simplex virus-specific cytotoxic T-lymphocyte clones recognize diverse virion protein antigens

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301503

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3301503

1 reference

Dimensions Publication ID

15 December 2017

1040102395

0 references

1 reference